Khurram Jamil, Chief Medical Officer at GALECTIN THERAPEUTICS INC (GALT), sold 19,442 shares at $7.04 ($137K) on 2025-12-17, disclosed to the SEC on 2025-12-19.
Scheduled sale ($137k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.04 | 4,479 | $32K | 23.0% |
| 2 | $7.04 | 6,463 | $45K | 33.2% |
| 3 | $7.04 | 8,500 | $60K | 43.7% |
| Total | $7.04 avg | 19,442 | $137K | 100% |
| Filing → |
| GALT | SELL | 2026-06-25 | $24K | — | Filing → |
| GALT | SELL | 2026-05-28 | $2K | — | Filing → |
| GALT | SELL | 2026-01-06 | $465K | — | Filing → |